mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.053 |
0.3 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.3 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.3 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |